Apple is a market darling again
Apple is a market darling again

The company, which reports its quarterly earnings Tuesday, has once again become an investor favorite.


Earnings surprises translate into price appreciation.

By Jan 31, 2012 10:27AM

UpperCut Images/UpperCut Images/Getty ImagesBy Brian Bolan


Heartland Payment Systems (HPY) sees earnings surprises translate into price appreciation. With estimates moving higher, this stock is a Zacks #1 Rank (Strong Buy).


Heartland Payment Systems, Inc. provides bankcard payment processing services. It facilitates the exchange of information and funds between merchants and cardholder's financial institutions and offers electronic payment processing services to merchants.

Tags: HPY

Despite a tough economy, the managed-care industry leader continues to gain members and boost profits.

By Gene Marcial Jan 31, 2012 9:43AM
Andersen Ross/Brand X Pictures/Getty ImagesManaged-care companies aren't on Wall Street's favored list, so shares of the group remain on the ropes. Even industry leader UnitedHealth Group (UNH), which hit a 52-week high of $54 a share on Jan. 18, has been under pressure. The stock slipped to $50 on Jan. 26.


Even so, some investment pros see the stock's slippage as an opportunity to buy more shares. Some bulls see the stock, which had climbed to an all-time high of $63 in 2005, hitting $65 or more in 2012.

Tags: UNH

Social media will steal the spotlight this weekend.

By Motley Fool Pick of the Day Jan 30, 2012 6:00PM
By Sean Williams


The Super Bowl is the mecca of all holidays for me. OK, so it's not an actual holiday, but you couldn't drag me out of my house kicking and screaming if the Super Bowl is on TV.


It's also the mecca of all days for networking company NBC, owned by Comcast (CMCSA), because it will be raking in an average of $3.5 million per 30 seconds for the rights to advertise during the Super Bowl. Advertising prices have risen 50% in just the past 10 years, and ads are expected to generate in the neighborhood of $250 million just from this one game.


U.S. clearance is a major milestone, but Bydureon faces stiff competition from its fast-selling rival.

By Minyanville Jan 30, 2012 5:22PM
Image: Insurance Money (© Comstock Images/Jupiterimages)By Brett Chase

Shares of Amylin Pharmaceuticals (AMLN) climbed Monday after the biotech company won U.S. approval of its Bydureon diabetes drug.

Amylin shares rose over 17% to close at $14.26. The company's development partner, Alkermes (ALKS), didn't fare as well, ending the day slightly down. 

Global fundamentals suggest that this will not be a repeat of 2011's flame-out.

By Jim Cramer Jan 30, 2012 3:37PM

A year ago, we took off like a bat out of hell, and then we ran smack into what can only be called a bear market. We had the industrials crater, the banks give it up and the oils get crushed because of European woes, the latter being a total oddity, because oil never came in. The techs were awful, led by a faltering semiconductor group with a contagion that spread everywhere except for Apple (AAPL).


Once again, we have taken off with great gusto, the best rally since 1997, and it has been across the board, with the financials and techs leading the way and the industrials, such as Caterpillar (CAT) and Honeywell (HON), not that far behind.


A substantial number of subscribers are shifting from hybrid service to streaming only.

By Trefis Jan 30, 2012 2:42PM
Image: Watching television (© Frare/Davis Photography/Brand X/Corbis)Netflix (NFLX) recently released its fourth-quarter and full-year 2011 results. As the company returned to growth in terms of net unique subscribers, the stock jumped significantly. We have raised our fair value for Netflix to $133, which now stands at a premium of about 15% to the market price.

The earnings highlighted a couple of things -- Netflix is back on growth track and DVD subscribers continue to decline substantially. A little confusing? The point is that customers are not leaving Netflix as much as before and a substantial decline is coming from subscribers dropping hybrid service and moving to streaming only.  

The world's leading aluminum producer is focusing on building high-quality engineered products that boost margins.

By Trefis Jan 30, 2012 2:19PM
Image: Man checking car tire pressure © Tetra Images/Tetra images/Getty ImagesAlcoa (AA) is a business that is highly susceptible to global economic conditions. Decline in aluminum demand led to a fall in spot prices in the fourth quarter of 2011.

Consequently, the market has been quite harsh on the company's stock, pushing it down into single digits.  

These master limited partnerships offer an average yield of 5.6%.

By TheStockAdvisors Jan 30, 2012 1:57PM
Image: Elevated view of freight cars with coal © Joseph Sohm-Visions of America/Photodisc/Getty ImagesBy Stephen Leeb, The Complete Investor

In my view, master limited partnerships (MLPs) are probably the best hedge against rising energy prices.

Three favorites are Penn Virginia Resource Partners (PVR), ONEOK Partners (OKS), and Plains All American Pipeline (PAA). 

BlackRock says fast-growing economies could decouple as the developed world struggles, but a global recession is still possible.

By The Fiscal Times Jan 30, 2012 1:33PM
financial predictionBy Suzanne McGee, The Fiscal Times

 Do you feel lucky this year? 

If so, you might want to bet on the optimistic side of the theoretical coin toss that the strategy team at BlackRock Investment Institute proposed in its investment outlook analysis, The Year of Living Divergently.  

Commercial aviation business wins new orders, while defense business looks resilient despite US government cuts.

By Trefis Jan 30, 2012 12:42PM
Image: Airline (© Christie & Cole/Corbis)Boeing's (BA) 2011 fourth-quarter earnings, announced last week, have given investors cause for cheer. The aerospace company's fundamentals are quite strong and it's poised for solid gains in 2012, in our view.

Boeing tackled the uncertainties of global economic growth, defense budget pressures and contraction in cargo volumes in an admirable way.  

A Fox reporter says the social network is furious over Morgan Stanley's claims of trumping Goldman Sachs as the lead underwriter.

By Jonathan Berr Jan 30, 2012 12:08PM
As the frenzy leading up to Facebook's initial public offering heats up, a rumor is rumbling that the social network is angry with Morgan Stanley (MS).

According to Fox business reporter Charlie Gasparino, Facebook is upset that the bank was allegedly blabbing that it was close to securing the lead underwriting role in the social network's much-anticipated IPO, a spot that many pundits figured would go to rival Goldman Sachs (GS). Gasparino isn't revealing his source, and a spokesman for Morgan Stanley couldn't be be reached. 
Tags: GS

Goldman upgrades Citigroup and Morgan Stanley but downgrades Bank of America and JP Morgan.

By MSN Money Partner Jan 30, 2012 11:56AM
Information provided by

Monday's noteworthy upgrades include:
  • Citigroup (C) upgraded to Buy from Neutral at Goldman
  • Morgan Stanley (MS) upgraded to Conviction Buy from Neutral at Goldman
  • Zimmer (ZMH) upgraded to Overweight from Neutral at Piper Jaffray
  • AutoZone (AZO) upgraded to Neutral from Sell at Goldman
  • Microsoft (MSFT) upgraded to Overweight from Neutral at Atlantic Equities
  • Regeneron (REGN) upgraded to Buy from Neutral at BofA/Merrill
  • Motorola Solutions (MSI) upgraded to Buy from Hold at Argus

For these supermarket giants, paying more attention to prices would better support stock valuations -- if it's not too late.

By Minyanville Jan 30, 2012 11:37AM

George Doyle/Stockbyte/Getty ImagesBy Ronald Thomas, CFA

I have always thought that too many investment analysts, at least where the consumer sector is concerned, do not pay enough attention to marketing and marketing strategy, and spend too much time playing with financial ratios. Many analysts overlook the relative prices companies charge consumers versus their competitors. They then do not sound an alarm for potential future market share losses and the effect that will have on stock valuations. In the food retailing area, Safeway (SWY) and SurperValu (SVU) are examples.

Safeway's prices are about 18% higher than Walmart's (WMT), and 11% higher than Kroger (KR).


The maker of Enfamil was cleared in a recent health scare, but it may be too late to prevent other pressures from biting at the stock.

By Jan 30, 2012 11:08AM

By Jim Jubak

Mead Johnson Nutrition (MJN) on Thursday reported fourth-quarter earnings of 52 cents a share, a penny above Wall Street estimates, and revenue of $911.3 million, above the Wall Street consensus of $894.04 million.


On the news, the stock closed up at $74.01. That $74 a share was the price I set for an exit in the aftermath of the death of a baby in Missouri that had consumed the company's Enfamil baby formula from a Cronobacter infection. 


To me, the stock is now a sell.


One analyst makes a case for boosting the stock's price target to $650.

By TheStockAdvisors Jan 30, 2012 10:47AM
By Geoffrey Seiler,

Apple (AAPL) has returned to its winning ways, reporting that it had more than doubled its profit and totally blowing away sales expectations for its iPhone and iPad and its Mac computers.

Revenue surged by 73% year over year. It was an absolute monster quarter. The results easily outdistanced the already heady expectations for holiday sales. The company sold 37.04 million iPhones worldwide, up 128% from a year ago. It sold 15.43 million iPads, 111% better than the year-earlier period. 


Copyright © 2014 Microsoft. All rights reserved.

Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.


StockScouter rates stocks from 1 to 10, with 10 being the best, using a system of advanced mathematics to determine a stock's expected risk and return. Ratings are displayed on a bell curve, meaning there will be fewer ratings of 1 and 10 and far more of 4 through 7.

124 rated 1
279 rated 2
454 rated 3
606 rated 4
675 rated 5
690 rated 6
622 rated 7
453 rated 8
301 rated 9
111 rated 10

Top Picks


Trending NOW

What’s this?



Quotes delayed at least 15 min


Top Stocks provides analysis about the most noteworthy stocks in the market each day, combining some of the best content from around the MSN Money site and the rest of the Web.

Contributors include professional investors and journalists affiliated with MSN Money.

Follow us on Twitter @topstocksmsn.


There’s a problem getting this information right now. Please try again later.
There’s a problem getting this information right now. Please try again later.
Market index data delayed by 15 minutes

[BRIEFING.COM] The S&P 500 has extended its gain to 0.6% with the health care sector (+1.0%) remaining ahead of the other nine groups.

Unlike the health care space, all of the remaining countercyclical sectors trail the broader market. The telecom services sector (+0.1%) continues holding a slim gain with Verizon (VZ 50.83, +0.13) up 0.2% in reaction to its earnings beat, while consumer staples (-0.2%) and utilities (-0.02%) hover in the red.

Notably, the staples ... More


There’s a problem getting this information right now. Please try again later.